uniQure (QURE) Research & Development (2016 - 2026)
uniQure (QURE) reported Research & Development of $33.96 million for Q2 2026, down 4.0% from $35.38 million a year earlier but up 16.4% from the prior quarter.
Powered by 
Analysis
uniQure (QURE) Research & Development (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, uniQure's Research & Development came in at $132.29 million, down 6.1% year-over-year; for FY2025, it was $140.67 million, down 2.2% from FY2024.
- Research & Development has a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
- By year, Research & Development came in at $143.78 million in FY2024 (-33.1%), $214.86 million in FY2023 (+8.7%), $197.59 million in FY2022 (+37.6%) and $143.55 million in FY2021 (+17.3%).
- Five-year quarterly Research & Development spans a low of $29.18 million in Q1 2026 and a high of $65.4 million in Q3 2023.
- Year over year, Research & Development has now declined in each of the last three quarters, with an average decline of 11.2% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2022 (growth of 41.1%); the low point was Q3 2024 (a decline of 53.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $29.18 million (Q1 2026), $34.78 million (Q4 2025) and $34.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | uniQure | 1.51 Bn | -1.21 Bn | 5.49 Mn | 33.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.96 Mn |
| Mar 31, 2026 | 29.18 Mn |
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Jun 30, 2025 | 35.38 Mn |
| Mar 31, 2025 | 36.14 Mn |
| Dec 31, 2024 | 38.84 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 33.66 Mn |
| Mar 31, 2024 | 40.69 Mn |
| Dec 31, 2023 | 42.62 Mn |
| Sep 30, 2023 | 65.40 Mn |
| Jun 30, 2023 | 46.04 Mn |
| Mar 31, 2023 | 60.81 Mn |
| Dec 31, 2022 | 58.33 Mn |
| Sep 30, 2022 | 48.07 Mn |
| Jun 30, 2022 | 46.19 Mn |
| Mar 31, 2022 | 45.00 Mn |
| Dec 31, 2021 | 42.34 Mn |
| Sep 30, 2021 | 36.43 Mn |
API Access
uniQure Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();